Stock Market News2 months How to Play LLY Stock as Zepbound Beats NVO’s Wegovy in Obesity Study Zacks
The latest Zepbound data bodes well for Lilly and could help establish the drug as the new standard for obesity medications.
XThe latest Zepbound data bodes well for Lilly and could help establish the drug as the new standard for obesity medications.
X